Top compounds associated with response to CDC25C


Feature Type Standardized
Nominal ANOVA
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.001
mRNA Methotrexate CTRPv2 pan-cancer AAC 0.12 0.002
mRNA RDEA119 GDSC1000 pan-cancer AAC -0.095 0.002
mRNA austocystin d CTRPv2 pan-cancer AAC -0.12 0.002
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.002
mRNA PD 153035 CTRPv2 pan-cancer AAC -0.13 0.002
mRNA PD318088 CTRPv2 pan-cancer AAC -0.11 0.002
mRNA trifluoperazine CTRPv2 pan-cancer AAC -0.12 0.002
mRNA VX-11e GDSC1000 pan-cancer AAC -0.096 0.003
mRNA Teniposide CTRPv2 pan-cancer AAC 0.12 0.004
Download CSV